A01K 2267/01
Animal expressing industrially exogenous proteins
A01K2267/01 (Animal expressing industrially exogenous proteins) appears on 776 US grants and 1,227 published applications in this corpus.
Search patents in A01K- Granted patents
- 776
- Published applications
- 1,227
- Assignees
- 452
- Inventors
- 1,430
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 21 | 0 |
| 1998 | 28 | 0 |
| 1999 | 23 | 0 |
| 2000 | 29 | 0 |
| 2001 | 20 | 6 |
| 2002 | 15 | 45 |
| 2003 | 20 | 60 |
| 2004 | 17 | 62 |
| 2005 | 9 | 63 |
| 2006 | 30 | 61 |
| 2007 | 12 | 33 |
| 2008 | 24 | 34 |
| 2009 | 27 | 53 |
| 2010 | 16 | 42 |
| 2011 | 27 | 37 |
| 2012 | 22 | 34 |
| 2013 | 20 | 57 |
| 2014 | 18 | 68 |
| 2015 | 32 | 69 |
| 2016 | 48 | 54 |
| 2017 | 36 | 72 |
| 2018 | 40 | 46 |
| 2019 | 33 | 53 |
| 2020 | 41 | 56 |
| 2021 | 34 | 60 |
| 2022 | 25 | 31 |
| 2023 | 25 | 29 |
| 2024 | 23 | 53 |
| 2025 | 29 | 24 |
| 2026 | 14 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Single chain VH and heavy chain antibodies25 Aug 2026US 12,715,906 B2Trianni, Inc.
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Cells, vertebrates, populations and methods4 Aug 2026US 12,696,885 B2Kymab Limited
- VHH-containing heavy chain antibody and production thereof7 Jul 2026US 12,673,984 B2Universitätsklinikum Hamburg-Eppendorf
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
- Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion3 Sep 2026US 2026/0256123 A1Crystal Bioscience Inc.
- Non-Human Animals Expressing Humanized CD3 Complex13 Aug 2026US 2026/0231915 A1Regeneron Pharmaceuticals, Inc.
- System and method for oral vaccination of animal populations via transgenic insects13 Aug 2026US 2026/0231916 A1Future Fields Cellular Agriculture and Research LTD.
- Modified madariaga viruses, self-replicating rna constructs, and uses thereof30 Jul 2026US 2026/0218170 A1Replicate Bioscience, Inc.
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996